Antidepressant Treatment Outcome Depends on the Quality of the Living Environment: A Pre-Clinical Investigation in Mice
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Antidepressants represent the standard treatment for major depression. However, their efficacy is variable and incomplete. A growing number of studies suggest that the environment plays a major role in determining the efficacy of these drugs, specifically of selective serotonin reuptake inhibitors (SSRI). A recent hypothesis posits that the increase in serotonin levels induced by SSRI may not affect mood per se, but enhances neural plasticity and, consequently, renders the individual more susceptible to the influence of the environment. Thus, SSRI administration in a favorable environment would lead to a reduction of symptoms, while in a stressful environment might lead to a worse prognosis. To test this hypothesis, we treated C57BL/6 adult male mice with chronic fluoxetine while exposing them to either (i) an enriched environment, after exposure to a chronic stress period aimed at inducing a depression-like phenotype, or (ii) a stressful environment. Anhedonia, brain BDNF and circulating corticosterone levels, considered endophenotypes of depression, were investigated. Mice treated with fluoxetine in an enriched condition improved their depression-like phenotype compared to controls, displaying higher saccharin preference, higher brain BDNF levels and reduced corticosterone levels. By contrast, when chronic fluoxetine administration occurred in a stressful condition, mice showed a more distinct worsening of the depression-like profile, displaying a faster decrease of saccharin preference, lower brain BDNF levels and increased corticosterone levels. Our findings suggest that the effect of SSRI on depression-like phenotypes in mice is not determined by the drug per se but is induced by the drug and driven by the environment. These findings may be helpful to explain variable effects of SSRI found in clinical practice and to device strategies aimed at enhancing their efficacy by means of controlling environmental conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 3×
“By contrast, SSRI are more effective in patients with high socioeconomic status [4].”
BackgroundInfluentialKirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 1×
“In particular, results indicate that a switch from an enriched to a stressful environment increases anhedonia in control mice, in line with the literature [41,42] and that FLX amplifies such effect.”
ResultNemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 1×
“, loss of interest or pleasure in normal activities -- one of the nine symptoms defined by the Diagnostic and Statistic Manual (DSM-IVTR) for major depression, which has been successfully translated in mice [24]; (b) BDNF levels, reported to be reduced in depressed patients [25,26] and increased by antidepressant admi…”
BackgroundBinder (2004) · doi:10.1080/08977190410001723308 · Cited by 1,481
Socioeconomic status and the brain: mechanistic insights from human and animal research
Hackman, D. A., Farah, M. J., & Meaney, M. J. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2897 · Cited by 1,409
The Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198 · cited 1×
“, loss of interest or pleasure in normal activities -- one of the nine symptoms defined by the Diagnostic and Statistic Manual (DSM-IVTR) for major depression, which has been successfully translated in mice [24]; (b) BDNF levels, reported to be reduced in depressed patients [25,26] and increased by antidepressant admi…”
BackgroundShimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 2×
“In addition, the association between the low BDNF levels and the anhedonic profile, indicative of a depression-like phenotype, is in line with studies in patients [26,27,28].”
BackgroundResultVulnerability genes or plasticity genes?
Belsky, J., Jonassaint, C., Pluess, M., Stanton, M., Brummett, B., & Williams, R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.44 · Cited by 1,017 · cited 2×
“In support to this hypothesis, a number of indirect evidences both from clinical and preclinical studies indicate that increased serotonin levels lead to greater brain plasticity and higher susceptibility to environmental inputs [14,16,17,18,19,20].”
BackgroundThe antidepressant fluoxetine restores plasticity in the adult visual cortex
Vetencourt, J. F. M., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., F. O'Leary, O., Castrén, E., & Maffei, L. (2008) · Science · doi:10.1126/science.1150516 · Cited by 890
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730 · cited 1×
“Indeed, antidepressants are among the most prescribed drugs in western countries [69].”
BackgroundEffects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300433 · Cited by 671 · cited 1×
“with saccharin) drunk by treated mice allowed to reach an effective FLX serum level around 150 ng/ml, as shown in previous studies [39].”
Gene–environment interaction analysis of serotonin system markers with adolescent depression
Eley, T. C., Sugden, K., Corsico, A., Gregory, A. M., Sham, P., McGuffin, P., Plomin, R., & Craig, I. W. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001546 · Cited by 663 · cited 1×
“For instance, clinical studies investigating variations of the serotonintransporter–linked polymorphic region, 5-HTTLPR, found that individuals bearing the s/s variant, associated with higher brain extracellular levels of serotonin, show an enhanced behavioral plasticity and susceptibility to the influence of the envi…”
BackgroundBessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598 · cited 2×
“The latter finding, replicated twice in the present study, is not in line with some previous data indicating an increased preference for the sweet solution following SSRI administration [43,44].”
ResultThe glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592 · cited 1×
“With regard to HPA axis activity, though some studies described a reduction of corticosterone levels [58,59], mainly mediated by an increased expression of glucocorticoid receptors [60], others have indicated opposite effects [61,62].”
BackgroundRidder, S., Chourbaji, S., Hellweg, R., Urani, A., Zacher, C., Schmid, W., Zink, M., Hörtnagl, H., Flor, H., Henn, F. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0736-05.2005 · Cited by 382 · cited 1×
“The inverted relationship between corticosterone and BDNF levels found in mice exposed to either the enriched or the stressful condition has already been reported [63,64,65].”
BackgroundFear erasure in mice requires synergy between antidepressant drugs and extinction training
Karpova, N. N., Pickenhagen, A., Lindholm, J., Tiraboschi, E., Kulesskaya, N., Ágústsdóttir, A., Antila, H., Popova, D., Akamine, Y., Sullivan, R., et al. (2011) · Science · doi:10.1126/science.1214592 · Cited by 382
Active placebos versus antidepressants for depression
Moncrieff, J., Wessely, S., & Hardy, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003012.pub2 · Cited by 342
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341 · cited 1×
“, loss of interest or pleasure in normal activities -- one of the nine symptoms defined by the Diagnostic and Statistic Manual (DSM-IVTR) for major depression, which has been successfully translated in mice [24]; (b) BDNF levels, reported to be reduced in depressed patients [25,26] and increased by antidepressant admi…”
BackgroundWiles, N., Thomas, L., Abel, A., Ridgway, N., Turner, N., Campbell, J., Garland, A., Hollinghurst, S., Jerrom, B., Kessler, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61552-9 · Cited by 340 · cited 1×
“This could be achieved by training patients to cope with harsh environments, for instance through cognitive behavioral therapy [72], since it is unlikely that people can rapidly and effectively change their living milieu.”
BackgroundDias, B. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00198-9 · Cited by 274
The reciprocal interaction between serotonin and social behaviour
Kiser, D., SteemerS, B., Branchi, I., & Homberg, J. R. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.009 · Cited by 214
Self-citationBrummett, B. H., Boyle, S. H., Siegler, I. C., Kuhn, C. M., Ashley-Koch, A., Jonassaint, C. R., Züchner, S., Collins, A., & Williams, R. B. (2008) · Behavior Genetics · doi:10.1007/s10519-007-9172-1 · Cited by 201
Do antidepressants regulate how cortisol affects the brain?
Pariante, C. M., Thomas, S. A., Lovestone, S., Makoff, A., & Kerwin, R. W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.10.009 · Cited by 194
Branchi, I. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.011 · Cited by 156
Self-citationCitalopram counteracts depressive-like symptoms evoked by chronic social stress in rats
Rygula, R., Abumaria, N., Flügge, G., Hiemke, C., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000186631.53851.71 · Cited by 104 · cited 1×
“The latter finding, replicated twice in the present study, is not in line with some previous data indicating an increased preference for the sweet solution following SSRI administration [43,44].”
Result
Research works printed but not linked: 37
- N Balak, 2007, Costs of disorders of the brain in Europe, Eur J Neurol, 14, e9, 10.1111/j.1468-1331.2006.01570.x · DOI
- M Angell, 2008, Industry-sponsored clinical research: a broken system, JAMA, 300, 1069, 10.1001/jama.300.9.1069 · DOI · Paper page
- J Moncrieff, 2005, Efficacy of antidepressants in adults, BMJ, 331, 155, 10.1136/bmj.331.7509.155 · DOI · Paper page
- KN Fountoulakis, 2011, Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data, Int J Neuropsychopharmacol, 14, 405, 10.1017/S1461145710000957 · DOI · Paper page
- RH McAllister-Williams, 2008, Do antidepressants work? A commentary on "Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration" by Kirsch et al, Evid Based Ment Health, 11, 66, 10.1136/ebmh.11.3.66 · DOI · Paper page
- JR Homberg, 2012, Genetic sensitivity to the environment, across lifetime, Behav Brain Sci, 35, 368, 10.1017/S0140525X1200101X · DOI
- A Cohen, 2006, Social inequalities in response to antidepressant treatment in older adults, Arch Gen Psychiatry, 63, 50, 10.1001/archpsyc.63.1.50 · DOI · Paper page
- F Cirulli, 2009, The NGF saga: from animal models of psychosocial stress to stress-related psychopathology, Front Neuroendocrinol, 30, 379, 10.1016/j.yfrne.2009.05.002 · DOI · Paper page
- R Hellweg, 2008, Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment, Pharmacopsychiatry, 41, 66, 10.1055/s-2007-1004594 · DOI · Paper page
- M Nibuya, 1996, Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus, J Neurosci, 16, 2365, 10.1523/JNEUROSCI.16-07-02365.1996 · DOI · Paper page
- S Chourbaji, 2011, Altering BDNF expression by genetics and/or environment: impact for emotional and depression-like behaviour in laboratory mice, Neurosci Biobehav Rev, 35, 599, 10.1016/j.neubiorev.2010.07.003 · DOI
- S Chourbaji, 2012, The impact of environmental enrichment on sex-specific neurochemical circuitries - effects on brain-derived neurotrophic factor and the serotonergic system, Neuroscience, 220, 267, 10.1016/j.neuroscience.2012.06.016 · DOI
- S Chourbaji, 2008, Evaluation of effects of previous exposure to an acute stressor before testing for depression-like behaviours in mice, Stress, 11, 170, 10.1080/10253890701560119 · DOI
- I Branchi, 2010, Shaping brain development: mouse communal nesting blunts adult neuroendocrine and behavioral response to social stress and modifies chronic antidepressant treatment outcome, Psychoneuroendocrinology, 35, 743, 10.1016/j.psyneuen.2009.10.016 · DOI
- E Knapska, 2006, Differential involvement of the central amygdala in appetitive versus aversive learning, Learn Mem, 13, 192, 10.1101/lm.54706 · DOI · Paper page
- AO Mechan, 2009, A comparison of learning and memory characteristics of young and middle-aged wild-type mice in the IntelliCage, J Neurosci Methods, 180, 43, 10.1016/j.jneumeth.2009.02.018 · DOI
- T Strekalova, 2004, Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration, Neuropsychopharmacology, 29, 2007, 10.1038/sj.npp.1300532 · DOI · Paper page
- JC Brenes, 2009, The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum, Behav Brain Res, 198, 199, 10.1016/j.bbr.2008.10.036 · DOI
- MA Prendergast, 2002, Fluoxetine differentially suppresses sucrose solution consumption in free-fed and food-deprived rats--reversal by amantadine, Med Sci Monit, 8, BR385
- S Sammut, 2002, Antidepressant reversal of interferon-alpha-induced anhedonia, Physiol Behav, 75, 765, 10.1016/S0031-9384(02)00677-7 · DOI
- M Tonissaar, 2008, Rat behavior after chronic variable stress and partial lesioning of 5-HT-ergic neurotransmission: effects of citalopram, Prog Neuropsychopharmacol Biol Psychiatry, 32, 164, 10.1016/j.pnpbp.2007.08.001 · DOI
- AC Conti, 2002, cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs, J Neurosci, 22, 3262, 10.1523/JNEUROSCI.22-08-03262.2002 · DOI · Paper page
- JP Jacobsen, 2004, The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels, Brain Res, 1024, 183, 10.1016/j.brainres.2004.07.065 · DOI · Paper page
- ME Kozisek, 2008, Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies, Pharmacol Ther, 117, 30, 10.1016/j.pharmthera.2007.07.001 · DOI · Paper page
- X Miro, 2002, Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study, Neuropharmacology, 43, 1148, 10.1016/S0028-3908(02)00220-4 · DOI
- TS Zetterstrom, 1999, Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain, Neuropharmacology, 38, 1063, 10.1016/S0028-3908(99)00022-2 · DOI
- S Alboni, 2010, Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats, Eur J Pharmacol, 643, 180, 10.1016/j.ejphar.2010.06.028 · DOI · Paper page
- M Goekint, 2011, Influence of citalopram and environmental temperature on exercise-induced changes in BDNF, Neurosci Lett, 494, 150, 10.1016/j.neulet.2011.03.001 · DOI
- JD Uys, 2006, Early life trauma decreases glucocorticoid receptors in rat dentate gyrus upon adult re-stress: reversal by escitalopram, Neuroscience, 137, 619, 10.1016/j.neuroscience.2005.08.089 · DOI
- Q Shen, 2010, gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression, Biol Psychiatry, 68, 512, 10.1016/j.biopsych.2010.04.024 · DOI · Paper page
- CC Weber, 2006, Effects of antidepressants on the brain/plasma distribution of corticosterone, Neuropsychopharmacology, 31, 2443, 10.1038/sj.npp.1301076 · DOI
- A Berry, 2012, Social deprivation stress is a triggering factor for the emergence of anxiety- and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice, Psychoneuroendocrinology, 37, 762, 10.1016/j.psyneuen.2011.09.007 · DOI · Paper page
- JP Jacobsen, 2006, Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat, Brain Res, 1110, 221, 10.1016/j.brainres.2006.06.077 · DOI
- 2009, Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults, Soc Psychiatry Psychiatr Epidemiol, 44, 272, 10.1007/s00127-008-0436-8 · DOI · Paper page
- D Feifel, 2008, More depressing news on antidepressants: should we panic?, Psychiatry (Edgmont), 5, 35
- I Kirsch, 2002, Antidepressants and placebos: secrets, revelations, and unanswered questions, Prev Treat, 5, article 33
- J Moncrieff, 2003, A comparison of antidepressant trials using active and inert placebos, Int J Methods Psychiatr Res, 12, 117, 10.1002/mpr.148 · DOI
Cited by
Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
Mahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.009 · Cited by 694
Animal models of major depression: drawbacks and challenges
Planchez, B., Surget, A., & Belzung, C. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02084-y · Cited by 480
Andrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.018 · Cited by 281
“The evolution of the serotonergic system and its v. Rev. (2015), http://dx.doi.org/10.1016/j.neubiorev.2015.01.018 et al., 1999), anhedonia (Branchi et al., 2013; Harrison et al., 2001), and neurotrophin signaling (Bland et al., 2007; Freitas et al., 2013; Hellweg et al., 2007; Rasmusson et al.,…”
InfluentialThe serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology
Homberg, J. R., Molteni, R., Calabrese, F., & Riva, M. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.012 · Cited by 177
Rief, W., Barsky, A. J., Bingel, U., Doering, B. K., Schwarting, R., Wöhr, M., & Schweiger, U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.008 · Cited by 67
Metadata
- Authors
- Branchi, I., Santarelli, S., Capoccia, S., Poggini, S., D’Andrea, I., Cirulli, F., & Alleva, E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-30
- Volume
- 8
- Issue
- 4
- Pages
- e62226
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2074465939
- Cited by
- 102
- References
- 32
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.